Skip to content

Efficacy of Local Anesthetic for Postoperative Pain in Gynecologic Laparoscopy

Efficacy of the Analgesic Effect of Local Anesthetic Injection on Postoperative Pain in Gynecological Laparoscopic Surgeries: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07030647
Enrollment
90
Registered
2025-06-22
Start date
2024-03-01
Completion date
2025-03-30
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Laparoscopic Surgery, Pain Management, Postoperative Pain, Recovery Outcomes

Keywords

Gynecological laparoscopy, local anesthetic infiltration, postoperative pain, recovery, bupivacaine, port-site infiltration, Intraperitoneal local anesthetic

Brief summary

This is a randomized, double-blind, controlled clinical trial evaluating the efficacy of local anesthetic (LA) in reducing postoperative pain in patients undergoing gynecologic laparoscopic surgery. Ninety participants will be randomly assigned into three equal groups: Group A will receive LA injection at the port site, Group B will receive intraperitoneal LA injection, and Group C will serve as the control group with no LA intervention. Postoperative pain will be assessed and compared among the three groups.

Interventions

DRUGBupivacaine 0.25%

At the end of gynecologic laparoscopic surgery and prior to trocar removal, 40 mL of Bupivacaine 0.25% is instilled intraperitoneal under direct vision to evaluate its analgesic effect.

Sponsors

Usama Ahmed Elsaeed Salem, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Female participants aged 18 to 60 years Scheduled for elective gynecological laparoscopic procedures, including: Evaluation for primary or secondary infertility Assessment of suspected uterine pathology Evaluation of Müllerian anomalies Assessment of suspected tubal or peritoneal pathology requiring diagnostic exploration.

Exclusion criteria

Known allergy or hypersensitivity to local anesthetics (e.g., lidocaine or bupivacaine) Body Mass Index (BMI) ≥ 35 kg/m² Severe hepatic or renal impairment Chronic pain conditions requiring regular opioid use History of major abdominal surgery Refusal to provide informed consent or to enroll in the study

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain score assessed using the Visual Analog Scale .24 hours after surgeryPostoperative pain will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Time to First Analgesic Request24 hours after surgery

Secondary

MeasureTime frameDescription
Total Analgesic Consumptionwithin 24 hours after surgery
Patient Satisfaction Score24 hours postoperativelyPatient satisfaction will be measured using a10- point Likert Scale, where 1 = Very Dissatisfied and 10 = Very Satisfied. Higher scores indicate greater satisfaction.
Length of Hospital StayFrom end of surgery until hospital discharge assessed up to 7 daysThe duration (in hours) from the end of surgery to the time of hospital discharge will be recorded. This outcome measures the efficiency of recovery and readiness for discharge.
Time to First Patient AmbulationWithin 24 hours after surgery

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026